Abstract
The objective of this pilot study was to assess the reliability of superb microvascular ultrasound (SMI) for the measurement of the cerebrospinal fluid (CSF) flow within VPS systems as an indirect sign for shunt dysfunction. Asymptomatic hydrocephalus patients, with a VPS system implanted between 2017 and 2021, were prospectively enrolled in the study. Using SMI, the CSF flow within the proximal and distal catheters were analysed. Before and after pumping the shunt reservoir, intraabdominal free fluid, optical nerve sheath diameter (ONSD), and papilla diameter (PD) were evaluated and correlated with the amount of valve activation. Nineteen patients were included. A flow was detectable in 100% (N = 19) patients in the proximal and in 89.5% (N = 17) in the distal catheter. The distal catheter tip was detectable in 27.7% (N = 5) patients. Free intraabdominal fluid was initially detected in 21.4% (N = 4) patients and in 57.9% (N = 11) at the end of the examination (P = 0.049). ONSD was significantly lower after pump activation (4.4 ± 0.9 mm versus 4.1 ± 0.8 mm, P = 0.049). Both peak velocity and flow volume per second were higher in proximal compared to distal catheters (32.2 ± 45.2 versus 5.6 ± 3.7 cm/sec, P = 0.015; 16.6 ± 9.5 ml/sec versus 5.1 ± 4.0 ml/sec, P = 0.001, respectively). No correlation was found between the number of pump activations and the changes in ONSD (P = 0.975) or PD (P = 0.820). SMI appears to be a very promising non-invasive diagnostic tool to assess CSF flow within the VPS systems and therefore affirm their function. Furthermore, appearance of free intraperitoneal fluid followed by repeated compression of a shunt reservoir indicates an intact functioning shunt system.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Ventriculoperitoneal shunt (VPS) dysfunctions represent a true emergency, conceivably terminating lethally [1,2,3,4]. VPS have a high failure rate up to 40% within the first year after initial implantation and up to 98% within the next 10 years [5,6,7]. The most common complications are infections and mechanical dysfunction [3, 8, 9].Symptoms indicating this serious condition oftentimes vary extensively from headache, nausea and emesis to coma and death. Correspondingly, patients may deteriorate rapidly with far-reaching aftermaths [10,11,12]. Importantly, 10% of all fatalities in children with implanted VP-shunts are due to a shunt dysfunction [13]. In order to rule out VPS malfunction, multimodal emergency cranial imaging is necessary to evaluate e.g. ventricular size [14]. Plain radiographic shunt series exclude disconnections or malposition and assess the valve setting in case of programmable systems [15]. Elevated intraventricular pressure without ventriculomegaly can be found in long-term VPS patients with long-term inserted VPS leading to a reduced ventricular compliance with no or minimal change of the width of the ventricular system in cranial imaging despite elevated intracranial pressure [16]. This possibility in a rapidly deteriorating symptomatic patient along with the absence of ventriculomegaly calls for explorative surgery and VPS revision. This may cause frustration of patients as well as physicians [1, 2] as revision surgery is associated with an high rate of subsequent VPS dysfunctions and infections [2, 17, 18].Hence, a strong call for reliable, predominantly non-invasive diagnostic tools has ascended recently. Being on the front burner, ultrasound (US) especially the contemporaneous advanced devices and techniques such as measuring of the optic nerve sheath diameter (ONSD), enables to steer coincident trend in diagnostics and treatment. Notably, none of these modern non-invasive methods available is embodied in the current standards of care yet. Using these in a preoperative diagnostic approach, especially as a bundle of non-invasive diagnostic procedures available may substantially expedite already very demanding time-consuming task and thus ameliorate patient outcomes in a real-world setting.Utilizing one of the contemporary advanced US techniques available, the aim of this feasibility study was to measure the cerebrospinal fluid (CSF) flow within the VPS system using US with a special focus on low velocity flow after compressing the reservoir chamber in asymptomatic patients regardless of the indication of VPS implantation. This technique may spare future surgical explorations when comparing the current value to the patients’ baseline.
Materials and methods
A single-center feasibility study was initiated to evaluate the potential of an additional ultrasound examination in VPS patients. This study was approved by the local ethics committee of Medical University Innsbruck, Austria (AN EK Nr:1300/2020) and was initiated in 2021.Detailed information including demographics, medical history, radiographic data and clinical presentation were collected. Medical history included the etiology of hydrocephalus, prior surgeries and the type of shunt system implanted. During the clinical check-up disease-related data (i.e., headache, nausea, dizziness, meningism, vomiting, stomachache, reduction of vigilance, orthostatic hypotension, scarring, infect signs) were extracted and a detailed neurologic examination was performed.
Radiographic data
A Canon Aplio i800 device (Tokyo, Japan) was used, performing SMI ultrasound with an 11 MHz linear array transducer. A superb microvascular imaging (SMI) standard imaging protocol was created directly on the Aplio i800 device, in accordance with Canon application specialists, named “VP shunt”. Of note, SMI is a novel US imaging technique enabling the visualization of low velocity blood flow in small vessels. The essential novel technical development of this new US procedure is based on the fact that noise generated from motion artifacts can be completely suppressed. The images include a monochrome color map of blood flow, which is registered onto the B-mode standard US image. The detection of flow within the catheter system was demonstrated by Putzer et al. in a separate experiment [21].Additionally, in the study we used ultrasonographic measurement of optic nerve sheath diameter (ONSD) for screening of suspected increased intracranial pressure (ICP) as the swelling of the optic nerve inside the eye, referred to as papilledema, is a known indicative parameter of increased ICP.The optic nerve was measured with the 11 MHz linear array transducer of the Canon Aplio i900 US device (Tokyo, Japan) in B-mode. The patients were in a supine position. Ultrasound gel was applicated on the closed eyelid and the probe was placed gently on top, avoiding increased manual pressure. Measurements of the ONSD were performed by an anterior transbulbar approach at a depth of 3 mm to the retinal surface on both sides.This technique enables fast and non-invasive assessment of a surrogate parameter for ICP.The ONSD was measured using the recently published suggested CLOSED Protocol for sonographic assessment of the optic nerve sheath diameter [22] and the papillary height was measured using the diagnostic protocol of Ebraheim et al. [23].
Clinical and radiological examinations of the ventriculoperitoneal shunt system
All patients received a clinical examination with further imaging only in case of new clinical manifestations. This included disease-related data, e.g., headache, nausea, dizziness, meningism, vomiting, stomach ache, reduction of vigilance, orthostatic hypotension, scarring, and infect signs.The function of the reservoir was checked by pushing the valve. In a next step the ventricular catheter was closed by pushing on the ventricular catheter (directly before the valve) and activating the reservoir. In pristine condition the reservoir is squeezed out with locking the ventricular catheter and the refilling of the pump chamber is evaluated after release of the ventricular catheter. The filling phase of the reservoir after release was assessed and characterized by followed: the refilling of the reservoir was prompt, delayed (> 5 s), or there was no refilling. The presence of a flow pattern upon SMI ultrasound was used to verify a normally functioning shunt system. In case of absence of a flow wave pattern, the ultrasound transducer was placed on the proximal and on the distal catheter for the purpose of differentiating proximal from distal shunt obstruction.
Statistical analysis
All data were collected and stored in Microsoft Excel (Microsoft Corp.; Redmond, USA). Statistical analysis was performed in GraphPad Prism 9.1.1 (GraphPad Software Inc.; La Jolla, USA). Continuous data are presented as box-plots including median and lower/upper quartiles, whiskers denote 5% and 95% percentiles; outliers are presented as circles. 95% confidence intervals (CI) are given where appropriate. P-values < 0.05 were considered significant, those < 0.1 a trend.Contingency tables were analyzed via χ [2] tests. ONSD and papilla diameters between left and right eye were compared via a linear correlation analysis, results are given as slope (95% confidence intervals in brackets), R [2] and p-values. Further linear correlation analyses were carried out between optical nerve sheath and papilla diameters before and after pump activation as described above. Continuous data was compared via a paired t-test, when comparing contralateral sides.
Results
Patients
A total of 19 patients were prospectively enrolled in the study. All patients had received a VPS between October 2017 and March 2021. The average age of the patients was 57.3 ± 13.5 years (range 29 to 75 years), and 15 patients were females (83.3%). All patients (N = 19) harbored a VPS shunt with a programmable valve together with a pumpable reservoir. Used valves, clinical symptoms and causes of hydrocephalus are listed in Table 1. On average, patients had 79.3 ± 17.3 kg body weight, 166.1 ± 7.9 cm body height and a BMI of 28.7 ± 6.2 kg/m2. The mean time from shunt implantation to US investigation of the VPS systems was 28.5 ± 21.4 months with 3 (15.8%) patients after additional catheter revision 17.3 ± 20.1 months prior to the current examination. Three (15.8%) patients received further imaging after onset of new deteriorating symptoms. Two (10.5%) patients received a cranial computed tomography (CT) and X-ray of the shunt valve (for confirmation of the initial setting), and the ventricular as well as the peritoneal catheters to exclude any disconnections. One (5.3%) patient received a cranial CT scan only. All patients needed no further intervention, and the US data was not used for decision-making.
General examination parameters, clinical conditions & implanted systems of patients
The average valve-pressure setting was 124.5 ± 17.8 mmH2O (90–140 mmH2O). The valve mechanism was activated 39.1 ± 16.4 times on average (range 14 to 80 times). Fourteen (73.7%) patients were asymptomatic, whereas five (26.3%) of the patients presented with temporary clinical symptoms. The clinical symptoms and implanted valve types are listed in Table 1.
Mechanical behavior and inspection of the valve
All 19 (100%) implanted valves were easy to compress and showed a repeatable prompt release after pumping the reservoir of the valve. With manual occlusion of the ventricular catheter (before the valve) and pumping the reservoir, 14 (73.7%) reservoirs stayed dented and filled up immediately after release of the ventricular catheter. In five (26.3%) patients the ventricular catheter could not be compressed.
CSF flow within the ventriculoperitoneal shunt system
A flow was detected in 19 (100%) patients in the proximal catheter in and in 17 (89.5%) patients in the distal catheter direct above the clavicula of the VPS (Fig. 1).
CFS flow direction was verified in 10 (52.6%) patients, in all these cases showing a cranial to peritoneal flow direction. There was a significant difference in peak velocity between the proximal and distal shunt Sect. (32.2 ± 45.2 vs. 5.6 ± 3.7 cm/sec, P = 0.015) as well as the flow volume per second (16.6 ± 9.5 mL/sec vs. 5.1 ± 4.0 ml/sec, P = 0.001) (Fig. 3).
Visualization of the distal catheter tip and free intraabdominal fluid
The peritoneal catheter tip was visualized by ultrasound in 5 (26.3%) patients. Free intraabdominal fluid was detected in 4 (21.1%) patients in the beginning of examination and in 11 (57.9%) patients after valve activation, respectively (P = 0.049) (Fig. 1).
Optical nerve sheath diameter
ONSD were significantly lower after reservoir activation (4.4 ± 0.9 mm vs. 4.1 ± 0.8 mm, P = 0.049) (Fig. 2). There was a strong correlation between the left and right ONSD before activation (slope 0.91 [95% CI 0.62 to 1.19], R [2] 0.72, P < 0.0001), which was significantly lower after pump activation (slope 0.84 [95% CI 0.10 to 1.57], R [2] 0.27, P = 0.028). The correlation between the bilateral ONSD before and after pump activation was moderate (slope 0.63 [95% CI 0.42 to 0.84], R [2] 0.53, P < 0.0001).
Papilla diameter
PD did not change after pumping the reservoir (2.0 ± 0.6 mm vs. 1.9 ± 0.5 mm, P = 0.124) (Fig. 2). Left- and right-sided PD highly correlated before (slope 0.87 [95% CI 0.51 to 1.24], R [2] 0.60, P = 0.0001) and after (slope 0.87 [95% CI 0.60 to 1.14], R [2] 0.75, P < 0.0001) valve activation, respectively. The correlation between the bilateral PD before and after pump activation was moderate (slope 0.54 [95% CI 0.37 to 0.71], R [2] 0.55, P < 0.0001).
Correlation between numbers of valve activation and ONSD / PD
The valve mechanism was activated 39.1 ± 16.4 times (range 14–80 times). No correlation was found between the number of activations and the changes in ONSD (P = 0.975) or papilla diameters (P = 0.820), respectively.
Discussion
Our prospective monocentric pilot study of consecutive patients with previously implanted programmable VPS due to symptomatic hydrocephalus uses a novel technology of superb microvascular ultrasound (SMI) to closely appraise the integrity and functionality of an inserted shunt system in a completely non-invasive manner. Our data demonstrate that this technique is capable of detecting CSF flow in the overwhelming majority of shunt patients, in our study in all patients in the proximal part, and in approximately 90% of patients in the distal part of the implanted shunt system. Moreover, flow volume as well as peak velocity could be measured and determined in detail, but depends on the angle of the probe, angle correction, settings on pulse repetition frequency [24]. Surprisingly, we found a higher peak velocity in the proximal parts of the shunt system compared to the distal ones. Free intraabdominal fluid was initially detected in approximately one fifth of patients, after active pumping of the shunt reservoir ascending to approximately two thirds of patients. This maneuver also significantly reduced the optic nerve sheath diameter. Our data strongly suggest that using this ultrasound technique, dysfunction of an implanted shunt system can be adequately detected and appraised in a non-invasive fashion.Ability to detect and measure the flow along with its quantification even in case of infinitesimal flow rates within an implanted VPS has been enabled owing to novel and constantly developing advancements in imaging techniques such as SMI ultrasound with special ultrasound probes [21]. Major merits of sonographic examinations are their cheapness and availability, no radiation, and the possibility to execute these bed-side [25]. Yet, the quality and value of the examination remains highly examiner reliant [26]. As for now, ultrasound has been routinely used to identify free intraabdominal fluid as an indirect sign of an intact shunt system [27]. Notably, the absence of free fluid within the abdomen represents certainly no proof of malfunction [27, 28]. In addition, the evidence of free intraabdominal fluid may also be physiological in women, children and young men [29]. In addition, there are several studies verifying the intact VPS function using ultrasound (US) by ultrasonically excited bubbles or by a characterization of valve interface oscillation [19, 20]. Putzer et al. created one of these models to detect very low flows and flow directions within catheters using ultrasound (US) [21]. In our study, we visualized the peritoneal catheter tip in one fourth and free intraabdominal fluid in one fifth of patients. Importantly, after active pumping of the shunt reservoir, this maneuver can indirectly verify the functionality of the shunt system. Subsequently, we found the intraabdominal fluid in approximately two thirds of patients, indicating a completely intact shunt system.It is worthy of notice that sonography has also been used to measure the diameter of the optic nerve sheath (ONSD), which simultaneously changes with rising, or decreasing ICP [30,31,32]. The measurement of ONSD appears to be more meaningful in case of a rapid elevation of ICP in comparison to the measurements of a congested papilla, which may be missing due to a delayed occurrence [33,34,35,36]. We were able to show a significant decrease of the ONSD after pump activation at the end of our examinations, whereas the measured papilla diameters did not change. Interestingly, there was no correlation between the number of pump activations and the changes in both ONSD and papilla diameters. Of note, the time course for development of papilledema varies widely, mostly depending on the slope of the ICP rise. Compensatory mechanisms may preclude the development of papilledema in chronic cases [37]. It is worthy of notice that the measurement of ONSD has emerged as a valuable non-invasive tool also in normal pressure hydrocephalus (NPH). In NPH, despite the typically normal baseline cerebrospinal fluid (CSF) pressures, fluctuations in ICP can occur, particularly during postural changes or transient CSF flow obstructions. ONSD measurement provides an indirect yet reliable indicator of these ICP variations, as the optic nerve sheath can expand in response to increased pressure. This parameter is particularly useful in differentiating NPH from other forms of hydrocephalus and intracranial hypertension, offering insights into the pathophysiology and aiding in the monitoring of therapeutic interventions. The non-invasive nature and ease of ONSD measurement further enhance its utility in both clinical and research settings, making it a significant adjunct in the comprehensive evaluation of patients with NPH.The exclusion criterion for our feasibility study was the type of implanted valve, specifically requiring a valve with an integrated reservoir chamber. These valves allow assessment of the filling phase. In all patients, the reservoirs refilled rapidly after releasing the reservoir chamber. To utilize this feature as an indicator of a functioning shunt system, we manually compressed the ventricular catheter while pumping the reservoir. This maneuver resulted in sustained emptying of the pump chamber in three-quarters of patients, with rapid refilling after releasing the catheter. However, in about one-quarter of patients, this method was not feasible, leading to immediate reservoir refilling. In cases of slit ventricles or overdrainage, slow reservoir reinflation can be observed. [11, 38] The failure rates of implanted VPS were reported to occur as often as 50% within the first year after implantation and up to 98% within the next 10 years, respectively [3, 7, 12]. The possibility of tumultuous clinical deterioration alongside the sundry symptoms [10,11,12] related to a shunt malfunction oftentimes result in a hasty vain surgical shunt exploration with a consecutively increased risk of further shunt failure 2 39. On average, these circumstances lead to 2.66 revisions per patients, with subsequently increased fears of patients having to undergo another surgical procedure and also a higher risk for subsequent revisions after initial revisions [2, 3, 12, 39, 40]. A key problem in the evaluation of ventricle size is the changed compliance of the ventricular system in long at least since several years implanted VPS patients, leading to only minor changes of the width of the ventricular system [16]. Rocque et al. describe a 93% positive predictive value using shunt tapping to detect a proximal shunt obstruction, independent of implanted systems [41]. However, a consecutive shunt infection remains feared, if performed incorrectly [42].In our pilot feasibility study, we were able to present several new indirect ultrasound imaging signs reflecting an intact and unobstructed VP-shunt system in healthy shunt patients. Pump activation of the valve led to a new occurrence of a free intraabdominal fluid as well as to a consecutive decrease of the ONSD. Furthermore, a flow within the proximal and distal catheter was measured and was used as a surrogate parameter. Further studies are required to evaluate potential changes of flow patterns in dysfunctional shunt systems. Ultimately, the way the pump chamber refills, also after squeezing and releasing the proximal catheter in combination with SMI ultrasound appears to be a promising, non-invasive, yet reliable approach to get relevant information regarding the integrity of the VPS system.
Strengths and limitations
Strengths
-
1.
Innovative Use of SMI Technology: The application of superb microvascular ultrasound (SMI) for assessing cerebrospinal fluid (CSF) flow in ventriculoperitoneal shunt (VPS) systems represents a novel, non-invasive diagnostic approach. This technique has the potential to enhance the evaluation of shunt function without the need for invasive procedures.
-
2.
Comprehensive Data Collection: The study included a detailed analysis of both proximal and distal catheter flow, optic nerve sheath diameter (ONSD), and the presence of intraabdominal fluid, providing a holistic assessment of shunt function.
-
3.
Clinical Relevance: By focusing on asymptomatic hydrocephalus patients with VPS, the study addresses a critical need for reliable, non-invasive methods to monitor shunt functionality, potentially reducing the need for exploratory surgeries.
Limitations
-
1.
Sample Size: The number of patients included in this feasibility study is relatively small, which may limit the generalizability of the findings. Larger studies are needed to validate the results and further refine the methodology.
-
2.
Ultrasound Equipment Quality: The reliability of our findings is influenced by the quality and capabilities of the ultrasound equipment used. While the Canon Aplio i800 device with an 11 MHz linear array transducer provided valuable data, variations in equipment quality could affect the reproducibility of the results.
-
3.
Operator Expertise: The accuracy of SMI and other ultrasound measurements can be highly operator-dependent. The experience and skill of the examining physician play a crucial role in obtaining reliable results. In our study, all examinations were performed by experienced clinicians, but this factor may introduce variability in different clinical settings.
-
4.
Technical Challenges: Certain technical aspects, such as the detection of flow direction and the precise measurement of ONSD, posed challenges. The variability in these measurements indicates a need for further standardization and refinement of the examination protocols.Of note, both comparatives analysis of ONSD and other parameters before and after valve activation were unblinded.
Conclusion
Ultrasound, especially a contemporary technology of superb microvascular ultrasound (SMI) might be a promising and helpful tool to assess the CSF flow within VPS systems and therefore affirm its function in a completely non-invasive manner. Furthermore, appearance of free intraperitoneal fluid followed by repeated compression of a shut reservoir indicates an intact functioning shunt system.
Data availability
No datasets were generated or analysed during the current study.
Abbreviations
- CSF:
-
Cerebro Spinal Fluid
- CT:
-
Computed Tomography
- ICP:
-
Intra Cranial Pressure
- MRI:
-
Cranial Magnetic Resonance Imaging
- ONSD:
-
Optic Nerve Sheet Diameter
- PD:
-
Papilla Diameter
- PT:
-
Peri Tonealfluid
- SMI:
-
Microvascularultra Sound
- SAH:
-
Sub Arachnoid Haemorrhage
- US:
-
Ultra Sound
- VPS:
-
Ventriculo Peritoneal Shunt
References
Ahmadvand S, Dayyani M, Etemadrezaie H et al (2020) Rate and risk factors of early ventriculoperitoneal shunt revision: a five-year retrospective analysis of a Referral Center. World Neurosurg Feb 134:e505–e511
Anderson IA, Saukila LF, Robins JMW et al (2018) Factors associated with 30-day ventriculoperitoneal shunt failure in pediatric and adult patients. J Neurosurg Mar 9(1):145–153
Ferras M, McCauley N, Stead T, Ganti L, Desai B (2020) Ventriculoperitoneal shunts in the Emergency Department: a review. Cureus Feb 3(2):e6857
Merkler AE, Ch’ang J, Parker WE, Murthy SB, Kamel H (2017) The rate of complications after ventriculoperitoneal shunt surgery. World Neurosurg Feb 98:654–658
Lee JK, Seok JY, Lee JH et al (2012) Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years. J Korean Med Sci Dec 27(12):1563–1568
Hasanain AA, Abdullah A, Alsawy MFM et al (2019) Incidence of and causes for Ventriculoperitoneal Shunt failure in children younger than 2 years: a systematic review. J Neurol Surg Part Cent Eur Neurosurg Jan 80(1):26–33
Garcia-Bonilla M, Harris CA, Bandyopadhyay S et al (2024) Reduction of cell surface attachment in experimental hydrocephalus using a novel ventricular catheter with modified tethered liquid perfluorocarbon. J Neurosurg Mar 1(3):627–638
Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg Feb 94(2):195–201
Simon TD, Hall M, Riva-Cambrin J et al (2009) Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr Aug 4(2):156–165
Mencser Z, Kopniczky Z, Kis D, Barzo P (2019) Slit Ventricle as a neurosurgical emergency: Case Report and Review of Literature. World Neurosurg Oct 130:493–498
Rekate HL (2008) Shunt-related headaches: the slit ventricle syndromes. Child’s Nerv System: ChNS : Official J Int Soc Pediatr Neurosurg Apr 24(4):423–430
Bergsneider M, Egnor MR, Johnston M et al (2006) What we don’t (but should) know about hydrocephalus. J Neurosurg Mar 104(3 Suppl):157–159
Acakpo-Satchivi L, Shannon CN, Tubbs RS et al (2008) Death in shunted hydrocephalic children: a follow-up study. Child’s Nerv System: ChNS : Official J Int Soc Pediatr Neurosurg Feb 24(2):197–201
Boyle TP, Paldino MJ, Kimia AA et al (2014) Comparison of rapid cranial MRI to CT for ventricular shunt malfunction. Pediatr Jul 134(1):e47–54
Vega RA, Buscher MG, Gonzalez MS, Tye GW (2013) Sonographic localization of a nonpalpable shunt: Ultrasound-assisted ventricular shunt tap. Surg Neurol Int 4:101
Engel M, Carmel PW, Chutorian AM (1979) Increased intraventricular pressure without ventriculomegaly in children with shunts: normal volume hydrocephalus. Neurosurg Nov 5(5):549–552
Piatt JH Jr., Carlson CV (1993) A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg Sep-Oct 19(5):233–241 discussion 242
Shah SS, Hall M, Berry JG, Slonim AD, Hornig GW, Sharma V (2009) A Multicenter study of factors influencing Cerebrospinal Fluid Shunt Survival in infants and children. Neurosurg Jun 1(6):E1206
Aralar A, Bird M, Graham R et al (2018) Assessment of Ventriculoperitoneal Shunt function using Ultrasound characterization of Valve Interface Oscillation as a Proxy. Cureus Feb 19(2):e2205
Lam KW, Drake JM, Cobbold RS (1999) Noninvasive cerebrospinal fluid shunt flow measurement by Doppler ultrasound using ultrasonically excited bubbles: a feasibility study. Ultrasound Med Biology Mar 25(3):371–389
Putzer D, Brawanski K, Verius M et al (2023) Noninvasive CSF shunt patency evaluation by superb microvascular imaging. Neurosurgical Rev Aug 1(1):190
Aspide R, Bertolini G, Albini Riccioli L, Mazzatenta D, Palandri G, Biasucci DG (2020) A proposal for a New Protocol for Sonographic Assessment of the Optic nerve sheath diameter: the CLOSED protocol. Neurocritical care Feb 32(1):327–332
Ebraheim AM, Mourad HS, Kishk NA, Badr Eldin N, Saad AA (2018) Sonographic assessment of optic nerve and ophthalmic vessels in patients with idiopathic intracranial hypertension. Neurol Res Sep 40(9):728–735
Meola M, Ibeas J, Lasalle G, Petrucci I (2021) Basics for performing a high-quality color Doppler sonography of the vascular access. J Vascular Access Nov 22(1suppl):18–31
Sgouros S, John P, Walsh AR, Hockley AD (1996) The value of colour Doppler imaging in assessing flow through ventriculo-peritoneal shunts. Child’s Nerv System: ChNS : Official J Int Soc Pediatr Neurosurg Aug 12(8):454–459
Jayanth A, Benabbas R, Chao J, Sinert R (2021) Diagnostic modalities to determine ventriculoperitoneal shunt malfunction: a systematic review and meta-analysis. Am J Emerg Med Jan 39:180–189
Fried AM, Adams WE Jr., Ellis GT, Hatfield DR, Walsh JW (1980) Ventriculoperitoneal shunt function: evaluation by sonography. AJR Am J Roentgenol May 134(5):967–970
Noetzel MJ, Baker RP (1984) Shunt fluid examination: risks and benefits in the evaluation of shunt malfunction and infection. J Neurosurg Aug 61(2):328–332
Brown SE, Dubbins PA (2012) Detection of free intraperitoneal fluid in healthy young men. J Ultrasound Medicine: Official J Am Inst Ultrasound Med Oct 31(10):1527–1530
Lochner P, Czosnyka M, Naldi A et al (2019) Optic nerve sheath diameter: present and future perspectives for neurologists and critical care physicians. Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol Dec 40(12):2447–2457
Lee SH, Yun SJ (2018) Optic nerve sheath diameter on facial CT: a tool to predict traumatic brain injury. Eur J Trauma Emerg Surgery: Official Publication Eur Trauma Soc Oct 15
Wang LJ, Chen HX, Chen Y, Yu ZY, Xing YQ (2020) Optic nerve sheath diameter ultrasonography for elevated intracranial pressure detection. Annals Clin Translational Neurol May 7(5):865–868
Corbett JJ (1986) Neuro-ophthalmologic complications of hydrocephalus and shunting procedures. Seminars Neurol Jun 6(2):111–123
Katz DM, Trobe JD, Muraszko KM, Dauser RC (1994) Shunt failure without ventriculomegaly proclaimed by ophthalmic findings. J Neurosurg Nov 81(5):721–725
Mizrachi IB, Trobe JD, Gebarski SS, Garton HJ (2006) Papilledema in the assessment of ventriculomegaly. J neuro-ophthalmology: Official J North Am Neuro-Ophthalmology Soc Dec 26(4):260–263
Lee HJ, Phi JH, Kim SK, Wang KC, Kim SJ (2017) Papilledema in children with hydrocephalus: incidence and associated factors. J Neurosurg Pediatr Jun 19(6):627–631
Rigi M, Almarzouqi SJ, Morgan ML, Lee AG (2015) Papilledema: epidemiology, etiology, and clinical management. Eye Brain 7:47–57
Ros B, Iglesias S, Martin A, Carrasco A, Ibanez G, Arraez MA (2018) Shunt overdrainage syndrome: review of the literature. Neurosurgical Rev Oct 41(4):969–981
Shuaib W, Johnson JO, Pande V et al (2014) Ventriculoperitoneal shunt malfunction: cumulative effect of cost, radiation, and turnaround time on the patient and the health care system. AJR Am J Roentgenol Jan 202(1):13–17
Stone JJ, Walker CT, Jacobson M, Phillips V, Silberstein HJ (2013) Revision rate of pediatric ventriculoperitoneal shunts after 15 years. J Neurosurg Pediatr Jan 11(1):15–19
Rocque BG, Lapsiwala S, Iskandar BJ (2008) Ventricular shunt tap as a predictor of proximal shunt malfunction in children: a prospective study. J Neurosurg Pediatr Jun 1(6):439–443
Spiegelman L, Asija R, Da Silva SL, Krieger MD, McComb JG (2014) What is the risk of infecting a cerebrospinal fluid-diverting shunt with percutaneous tapping? J Neurosurg Pediatr Oct 14(4):336–339
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Open access funding provided by University of Innsbruck and Medical University of Innsbruck.
Author information
Authors and Affiliations
Contributions
Conceptualization and design, K.B., O.P. and D. G.; methodology, K.B., H.G., M.V., L.G., and D.P.; acquisition of data, K.B., O.P., C.P.H., N.K., H.G., L.G., and D.P.; formal analysis, K.B., O.P., and D.P.; writing—original draft preparation, K.B.; writing—review and editing, O.P., C.P.H., N.K., C.T., E.R.G., H.G, M.V., L.G., D.P.; visualization, K. B.; supervision, O.P., C.T., and D.P. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Our trial was approved by the local ethics committee of the Medical University Innsbruck, Austria (AN EK Nr: 1300/2020). Prior to initial examination, all patients were thoroughly informed in advance. Thereafter, written informed consent was subsequently obtained from every patient according to Austrian legislation. Of note, every patient granted both consent to participate and consent to publish.
Conflict of interest
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Brawanski, K., Petr, O., Hernandez, C.P. et al. Superb microvascular ultrasound is a promising non-invasive diagnostic tool to assess a ventriculoperitoneal shunt system function: a feasibility study. Neurosurg Rev 47, 521 (2024). https://doi.org/10.1007/s10143-024-02665-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10143-024-02665-w